hospital outline

GFG (Global Fertility& Genetics) was established in 2016 and is headquartered in the core area of Manhattan (E57th Street), New York, adjacent to landmark buildings such as Fifth Avenue and Central Park. As a global high-end assisted reproduction brand founded by Chinese investment, GFG integrates the resources of senior reproduction experts in the United States and focuses on providing families around the world with third-generation in vitro fertilization (PGT), fertility preservation (frozen eggs/frozen sperm), LGBT family construction and diversified services such as third-party assisted reproduction.

Core Advantage

nSenior laboratory certification
The laboratory has been certified by CAP (American Association of Pathologists) and CLIA (Clinical Laboratory Improvement Amendment Plan), and only a few reproductive centers around the world have obtained this qualification.
The system employs photocatalytic oxidation combined with HEPA air filtration technology. This allows for real-time monitoring of the incubation environment, including temperature, humidity, and CO2/O2 concentrations. This ensures that the embryos develop in a clean and uncontaminated environment.
It is located in a safe area of New York, combining medical care with cultural tourism (a 10-minute walk from attractions such as the Empire State Building).

Located in a safe area of New York, this location combines medical services with cultural and tourism amenities. It’s only a 10-minute walk from attractions like the Empire State Building.

Theservice system is complete

Providesmultilingual services (Chinese/English/Japanese/Spanish) and 24-hour full-process management, covering cross-border medical coordination between China and the United States, legal support and postpartum rehabilitation guidance.
Ovarian PRP therapy: By injecting autologous platelet plasma to activate ovarian function, clinical cases show that the number of follicles in a 46-year-old woman has increased from 1-2 to 6.
Ovarian PRP therapy: This treatment involves injecting autologous platelet plasma to activate ovarian function. Clinical cases have shown that in a 46-year-old woman, the number of follicles increased from 1-2 to 6.
Microfluidic sperm selection technology: Approved by the FDA in 2018. This technology simulates natural migration processes to select sperm with high DNA integrity, thereby improving the success rate of embryo development.
Medical Equipment and Technology
EmbryoScope+™ Time Difference Monitoring System: Automatically captures embryo dynamics every 5-20 minutes to synthesize three-dimensional development images to avoid manual intervention; low light environment simulates uterine

conditions

Da Vinci Robot Surgery System: Accurately complete difficult operations such as minimally invasive surgery for endometriosis and uterine scar repair, reducing tissue trauma.
Da Vinci robotic surgery system: enables precise minimally invasive surgeries for endometriosis, as well as complex procedures such as scar tissue repair, thereby reducing tissue damage.

High-precision sperm analysis device: The fastest testing equipment in the world. It can comprehensively analyze sperm count, motility, morphology, and DNA fragmentation rate (DFI), thereby optimizing fertilization procedures.

Ifyou want to learn more about the multinational assisted reproduction program, you can also contact the customer service ofthe GFG Assisted Reproduction Center in New Yorkfor free consultation. Customer service telephone: 18101365219